n(g),n(g')-dimethyl-l-arginine has been researched along with Spondylitis, Ankylosing in 9 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Spondylitis, Ankylosing: A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.
Excerpt | Relevance | Reference |
---|---|---|
"For AS patients, the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), back pain VAS and patient's global activity of disease were calculated." | 2.78 | Disparate effects of anti-TNF-α therapies on measures of disease activity and mediators of endothelial damage in ankylosing spondylitis. ( Gąsowski, J; Grodzicki, T; Jeka, S; Korkosz, M; Leszczyński, P; Pawlak-Buś, K; Siedlar, M; Surdacki, A, 2013) |
" Elevated total methylated arginine load and decreased global arginine bioavailability ratio (GABR) indicate that NO metabolism is impaired in patients with AS." | 1.62 | Determination of serum methylarginine levels by tandem mass spectrometric method in patients with ankylosing spondylitis. ( Abusoglu, G; Abusoglu, S; Gezer, İA; Isik, K; Onmaz, DE; Sivrikaya, A; Unlu, A; Yerlikaya, FH, 2021) |
"Like rheumatoid arthritis, ankylosing spondylitis (AS) is also an inflammatory disease associated with accelerated atherosclerosis and the presence of metabolic syndrome (MeS) features." | 1.40 | IGF-1 and ADMA levels are inversely correlated in nondiabetic ankylosing spondylitis patients undergoing anti-TNF-alpha therapy. ( Blanco, R; Carnero-López, B; Genre, F; Gómez-Acebo, I; González-Gay, MA; González-Juanatey, C; Llorca, J; López-Mejías, R; Miranda-Filloy, JA; Pina, T; Rueda-Gotor, J; Ubilla, B; Villar-Bonet, A, 2014) |
"Endothelial dysfunction is present in ankylosing spondylitis (AS)." | 1.35 | Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis. ( Alacacioglu, A; Bilgir, O; Kebapcilar, L; Kozaci, DL; Sari, I; Taylan, A; Yildiz, Y; Yuksel, A, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 7 (77.78) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Onmaz, DE | 1 |
Isik, K | 1 |
Sivrikaya, A | 1 |
Abusoglu, S | 1 |
Gezer, İA | 1 |
Abusoglu, G | 1 |
Yerlikaya, FH | 1 |
Unlu, A | 1 |
Korkosz, M | 1 |
Gąsowski, J | 1 |
Surdacki, A | 1 |
Leszczyński, P | 1 |
Pawlak-Buś, K | 1 |
Jeka, S | 1 |
Siedlar, M | 1 |
Grodzicki, T | 1 |
Genre, F | 1 |
López-Mejías, R | 1 |
Rueda-Gotor, J | 1 |
Miranda-Filloy, JA | 1 |
Ubilla, B | 1 |
Villar-Bonet, A | 1 |
Carnero-López, B | 1 |
Gómez-Acebo, I | 1 |
Blanco, R | 1 |
Pina, T | 1 |
González-Juanatey, C | 1 |
Llorca, J | 1 |
González-Gay, MA | 1 |
Inci, U | 1 |
Yildiz, A | 1 |
Batmaz, I | 1 |
Tekbas, E | 1 |
Demirkol, S | 1 |
Ozturk, C | 1 |
Balta, S | 1 |
Unlu, M | 1 |
Arslan, Z | 1 |
Sari, I | 1 |
Kebapcilar, L | 1 |
Alacacioglu, A | 1 |
Bilgir, O | 1 |
Yildiz, Y | 1 |
Taylan, A | 1 |
Yuksel, A | 1 |
Kozaci, DL | 1 |
Kemény-Beke, Á | 1 |
Gesztelyi, R | 1 |
Bodnár, N | 1 |
Zsuga, J | 1 |
Kerekes, G | 1 |
Zsuga, M | 1 |
Biri, B | 1 |
Kéki, S | 1 |
Szodoray, P | 1 |
Berta, A | 1 |
Szekanecz, Z | 1 |
Szántó, S | 1 |
Erre, GL | 1 |
Sanna, P | 1 |
Zinellu, A | 1 |
Ponchietti, A | 1 |
Fenu, P | 1 |
Sotgia, S | 1 |
Carru, C | 1 |
Ganau, A | 1 |
Passiu, G | 1 |
Angel, K | 1 |
Provan, SA | 1 |
Mowinckel, P | 1 |
Seljeflot, I | 1 |
Kvien, TK | 1 |
Atar, D | 1 |
1 trial available for n(g),n(g')-dimethyl-l-arginine and Spondylitis, Ankylosing
Article | Year |
---|---|
Disparate effects of anti-TNF-α therapies on measures of disease activity and mediators of endothelial damage in ankylosing spondylitis.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arginine; Arthritis, Rhe | 2013 |
8 other studies available for n(g),n(g')-dimethyl-l-arginine and Spondylitis, Ankylosing
Article | Year |
---|---|
Determination of serum methylarginine levels by tandem mass spectrometric method in patients with ankylosing spondylitis.
Topics: Adult; Arginine; Biomarkers; Case-Control Studies; Female; Humans; Male; Spondylitis, Ankylosing; Ta | 2021 |
IGF-1 and ADMA levels are inversely correlated in nondiabetic ankylosing spondylitis patients undergoing anti-TNF-alpha therapy.
Topics: Adipokines; Antibodies, Monoclonal; Arginine; Female; Humans; Inflammation; Infliximab; Insulin-Like | 2014 |
Assessment of serum asymmetric dimethylarginine levels and left ventricular diastolic function in patients with ankylosing spondylitis.
Topics: Adult; Antirheumatic Agents; Arginine; Biological Products; Biomarkers; Blood Sedimentation; C-React | 2017 |
Is left ventricular diastolic function impaired in patients with ankylosing spondylitis?
Topics: Arginine; Diastole; Humans; Spondylitis, Ankylosing; Ventricular Function, Left | 2017 |
Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis.
Topics: Adult; Arginine; Biomarkers; Endothelin-1; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric O | 2009 |
Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Osteo | 2011 |
Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study.
Topics: Adult; Arginine; Arteries; Atherosclerosis; Carotid Artery, Common; Cross-Sectional Studies; Electro | 2011 |
The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness.
Topics: Adult; Antirheumatic Agents; Aorta; Arginine; Arthritis, Psoriatic; Arthritis, Rheumatoid; Blood Pre | 2012 |